WHO Launches Global Roadmap on High Blood Pressure in Pregnancy

The World Health Organization and its partners have launched a global roadmap to address high blood pressure disorders during pregnancy, including pre-eclampsia and eclampsia, which remain major causes of maternal and newborn illness and death.

Announced on 8 October 2026, the roadmap sets out coordinated action through 2035 and beyond, focusing on research, clinical guidance, access to medicines and diagnostic tools, implementation and accountability.

WHO estimates that hypertensive disorders complicate between 10 and 15 per cent of pregnancies worldwide and account for approximately 16 per cent of maternal deaths globally.

Why blood pressure monitoring matters

Pre-eclampsia is a potentially serious pregnancy complication commonly associated with high blood pressure and signs of damage to organs. It can develop during pregnancy and may also occur after childbirth.

Without timely recognition and appropriate treatment, these conditions can lead to severe complications for both mother and baby. Risks include seizures, stroke, premature birth, stillbirth and other life-threatening outcomes.

Regular antenatal appointments allow healthcare professionals to monitor blood pressure, assess symptoms and carry out additional tests when indicated. Early detection can help women receive treatment and referral before complications become severe.

Closing gaps in maternal healthcare

WHO says many countries continue to face shortages of reliable blood-pressure monitoring, urine protein testing, essential medicines, trained health workers and emergency obstetric services.

These gaps can delay diagnosis and treatment, particularly for women living in underserved communities or areas far from well-equipped health facilities.

The new roadmap aims to improve access to proven interventions while encouraging research into better ways to predict, prevent and treat hypertensive disorders of pregnancy.

What expectant mothers should do

Pregnant women should attend recommended antenatal appointments and follow advice from qualified healthcare providers. They should seek urgent medical assessment for warning signs such as a severe or persistent headache, vision changes, severe pain in the upper abdomen or sudden significant swelling.

These symptoms can have different causes, but during pregnancy they should not be ignored. Only a healthcare professional can assess whether they indicate pre-eclampsia or another condition.

The global initiative highlights a central message for maternal health: timely monitoring, accessible treatment and effective referral systems can make a substantial difference to the safety of pregnancy and childbirth.